Multiple Sclerosis-related Uveitis: Does MS Treatment Affect Uveitis Course?

Ocular Immunology and Inflammation
Léa JouveValérie Touitou

Abstract

Few data are available regarding the optimal treatment of multiple sclerosis (MS)-related uveitis. The aim of this study was to describe clinical features of MS-associated uveitis and determine how MS treatment affects the course of uveitis. Retrospective, multicenter study. Patients were divided into two groups according to the use (group 2) or not (group 1) of immunomodulatory drugs. Characteristics of uveitis and treatment were reviewed. A total of 68 eyes from 36 patients (17 in group 1 and 19 in group 2) were included. All patients were treated with topical and/or systemic steroids for uveitis. Uveitis occurred 1-17 years prior to neurologic symptoms in 78% of patients. Uveitis was more severe in group 2 (p<0.05), with a tendency toward a higher rate of chronic uveitis (p = 0.06). MS-related uveitis has often a favorable evolution. Patients on interferon-beta have more severe and chronic uveitis. As far as we are concerned, interferon-beta given on the sole indication of uveitis is not recommended. If steroid-sparing agent is required for intraocular inflammation, immunosuppressive drugs should be considered.

References

Jan 1, 1992·Annual Review of Immunology·R MartinD E McFarlin
Mar 1, 1992·The British Journal of Ophthalmology·A RothovaA Kijlstra
Feb 1, 1991·Ophthalmology·J I LimJ A Goodwin
Jul 1, 1989·Cleveland Clinic Journal of Medicine·D M MeislerR M Ransohoff
Feb 15, 1987·American Journal of Ophthalmology·E Bloch-Michel, R B Nussenblatt
Jun 3, 1972·Lancet·C JersildT Fog
Jan 1, 1995·Duodecim; lääketieteellinen aikakauskirja·M PaneliusJ Ruutiainen
Jan 1, 1997·American Journal of Ophthalmology·W M TangK Pierce
May 30, 1998·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·H L Weiner
Mar 18, 1999·Ophthalmology·S C RajaN M Bressler
Jul 13, 2001·Ocular Immunology and Inflammation·J F PrietoJ M Herreras
Jan 31, 2002·Annual Review of Medicine·B Mark Keegan, John H Noseworthy
Jul 10, 2003·Autoimmunity Reviews·Glinda S Cooper, Berrit C Stroehla
Jul 11, 2003·Ocular Immunology and Inflammation·Aniki Rothova
Oct 30, 2004·Ocular Immunology and Inflammation·Ghassan ZeinC Stephen Foster
Jan 22, 2005·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Gregory P HanesMichael S Lee
Sep 20, 2005·The British Journal of Ophthalmology·M D BeckerC Fiehn
Nov 12, 2005·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Mar 3, 2006·The New England Journal of Medicine·Chris H PolmanUNKNOWN AFFIRM Investigators
Jul 1, 2006·Wiener klinische Wochenschrift·Saskia M MacaTalin Barisani-Asenbauer
Jan 23, 2008·Multiple Sclerosis : Clinical and Laboratory Research·Julie Le ScanffSandra Vukusic
Oct 22, 2011·Lancet Neurology·Joep KillesteinChris H Polman
Jun 22, 2013·American Journal of Ophthalmology·Friederike MackensenMatthias D Becker

❮ Previous
Next ❯

Citations

Feb 12, 2017·Archivos de la Sociedad Española de Oftalmología·D Velazquez-VilloriaJ García-Arumí
Jul 12, 2017·Ocular Immunology and Inflammation·Emmett T CunninghamManfred Zierhut
Feb 6, 2020·European Journal of Ophthalmology·Abdulrahman F AlBloushiAhmed M Abu El-Asrar
Jul 24, 2020·Expert Review of Clinical Immunology·Carla GaggianoClaudia Fabiani
Feb 6, 2020·Japanese Journal of Ophthalmology·Toshikatsu KaburakiMakoto Aihara
Mar 15, 2018·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·N StübigerU Pleyer
Sep 22, 2020·Journal of Ophthalmic Inflammation and Infection·Scott Joseph Sonne, Bradley Thomas Smith
Feb 10, 2017·Drugs·Gregory HeathRichard Peter Gale
Dec 17, 2020·Acta Ophthalmologica·Pauline CasselmanPieter-Paul Schauwvlieghe
Jan 23, 2021·Asia-Pacific Journal of Ophthalmology·Lisia Barros FerreiraJustine R Smith
Aug 6, 2021·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Roshan DhanapalaratnamArun V Krishnan
May 15, 2020·Multiple Sclerosis and Related Disorders·Giuseppe LopalcoFlorenzo Iannone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical & Experimental Ophthalmology
H M Towler, S Lightman
Ocular Immunology and Inflammation
Ghassan ZeinC Stephen Foster
Duodecim; lääketieteellinen aikakauskirja
M PaneliusJ Ruutiainen
Developments in Ophthalmology
M C Carnahan, Debra A Goldstein
© 2022 Meta ULC. All rights reserved